{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:20:03Z","timestamp":1793596803342,"version":"4.5.0"},"reference-count":208,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>The term \u201cchronic lung allograft dysfunction\u201d has emerged to describe the clinical syndrome of progressive, largely irreversible dysfunction of pulmonary allografts. This umbrella term comprises 2 major clinical phenotypes: bronchiolitis obliterans syndrome and restrictive allograft syndrome. Here, we discuss the clinical manifestations, diagnostic challenges, and potential therapeutic avenues to address this major barrier to improved long-term outcomes. In addition, we review the immunologic mechanisms thought to propagate each phenotype of chronic lung allograft dysfunction, discuss the various models used to study this process, describe potential therapeutic targets, and identify key unknowns that must be evaluated by future research strategies.<\/jats:p>","DOI":"10.1097\/tp.0000000000005162","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T08:20:10Z","timestamp":1722932410000},"page":"454-466","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Chronic Lung Allograft Dysfunction: Clinical Manifestations and Immunologic Mechanisms"],"prefix":"10.1097","volume":"109","author":[{"given":"Amit I.","family":"Bery","sequence":"first","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Belousova","sequence":"additional","affiliation":[{"name":"Pneumology, Adult Cystic Fibrosis Center and Lung Transplantation Department, Foch Hospital, Suresnes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramsey R.","family":"Hachem","sequence":"additional","affiliation":[{"name":"Division of Respiratory, Critical Care, and Occupational Pulmonary Medicine, University of Utah School of Medicine, Salt Lake City, UT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Roux","sequence":"additional","affiliation":[{"name":"Pneumology, Adult Cystic Fibrosis Center and Lung Transplantation Department, Foch Hospital, Suresnes, France."},{"name":"Paris Transplant Group, INSERM U970s, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kreisel","sequence":"additional","affiliation":[{"name":"Department of Surgery, Washington University School of Medicine, St. Louis, MO."},{"name":"Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"R1-20250219","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.healun.2022.08.007","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-ninth adult lung transplantation report-2022; focus on lung transplant recipients with chronic obstructive pulmonary disease.","volume":"41","author":"Perch","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"R2-20250219","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.healun.2019.08.001","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match.","volume":"38","author":"Chambers","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R3-20250219","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/MOT.0000000000000753","article-title":"Survival in adult lung transplantation: where are we in 2020?","volume":"25","author":"Bos","year":"2020","journal-title":"Curr Opin Organ Transplant"},{"key":"R4-20250219","first-page":"713","article-title":"A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation.","volume":"12","author":"Cooper","year":"1993","journal-title":"J Heart Lung Transplant"},{"key":"R5-20250219","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.healun.2011.01.712","article-title":"Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.","volume":"30","author":"Sato","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R6-20250219","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment\u2014a consensus report from the Pulmonary Council of the ISHLT.","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R7-20250219","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.healun.2019.03.008","article-title":"Chronic lung allograft dysfunction: definition and update of restrictive allograft syndrome\u2014a consensus report from the Pulmonary Council of the ISHLT.","volume":"38","author":"Glanville","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R8-20250219","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1055\/s-0033-1348463","article-title":"Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).","volume":"34","author":"Verleden","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"key":"R9-20250219","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/TP.0b013e31822bf790","article-title":"Survival determinants in lung transplant patients with chronic allograft dysfunction.","volume":"92","author":"Verleden","year":"2011","journal-title":"Transplantation"},{"key":"R10-20250219","doi-asserted-by":"crossref","first-page":"12395","DOI":"10.3389\/ti.2024.12395","article-title":"Late-onset exudative pleural effusions without concomitant airway obstruction or lung parenchymal abnormalities: a novel presentation of chronic lung allograft dysfunction.","volume":"37","author":"Sindu","year":"2024","journal-title":"Transpl Int"},{"key":"R11-20250219","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.healun.2018.09.020","article-title":"Validation of a post-transplant chronic lung allograft dysfunction classification system.","volume":"38","author":"Van Herck","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R12-20250219","doi-asserted-by":"crossref","first-page":"e13781","DOI":"10.1111\/ctr.13781","article-title":"Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: a single-center study.","volume":"34","author":"Verleden","year":"2020","journal-title":"Clin Transplant"},{"key":"R13-20250219","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/TP.0b013e318286e076","article-title":"Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?","volume":"95","author":"Verleden","year":"2013","journal-title":"Transplantation"},{"key":"R14-20250219","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.healun.2016.03.022","article-title":"Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantation.","volume":"35","author":"Verleden","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"R15-20250219","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1111\/ajt.13281","article-title":"Impact of CLAD phenotype on survival after lung retransplantation: a multicenter study.","volume":"15","author":"Verleden","year":"2015","journal-title":"Am J Transplant"},{"key":"R16-20250219","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/tri.14157","article-title":"Significance of phenotype change after chronic lung allograft dysfunction onset.","volume":"34","author":"Fuchs","year":"2021","journal-title":"Transpl Int"},{"key":"R17-20250219","doi-asserted-by":"crossref","first-page":"e0260881","DOI":"10.1371\/journal.pone.0260881","article-title":"Disease progression in patients with the restrictive and mixed phenotype of chronic lung allograft dysfunction\u2014a retrospective analysis in five European centers to assess the feasibility of a therapeutic trial.","volume":"16","author":"Gottlieb","year":"2021","journal-title":"PLoS One"},{"key":"R18-20250219","doi-asserted-by":"crossref","first-page":"e0275563","DOI":"10.1371\/journal.pone.0275563","article-title":"Transition from BOS to RAS impairs prognosis after lung transplantation\u2014CLAD subtype analysis by CT volumetry.","volume":"17","author":"Per\u00e4kyl\u00e4","year":"2022","journal-title":"PLoS One"},{"key":"R19-20250219","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.healun.2020.04.012","article-title":"Risk assessment of chronic lung allograft dysfunction phenotypes: validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.","volume":"39","author":"Levy","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R20-20250219","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1513\/AnnalsATS.201510-719OC","article-title":"Validation and refinement of chronic lung allograft dysfunction phenotypes in bilateral and single lung recipients.","volume":"13","author":"DerHovanessian","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"R21-20250219","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.healun.2013.01.1054","article-title":"Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS).","volume":"32","author":"Sato","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R22-20250219","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.rmr.2023.01.025","article-title":"La dysfonction chronique du greffon pulmonaire en 2022: une entit\u00e9 mieux comprise et un d\u00e9fi th\u00e9rapeutique.","volume":"40","author":"Halitim","year":"2023","journal-title":"Rev Mal Respir"},{"key":"R23-20250219","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.healun.2021.08.003","article-title":"Abnormal one-year post-lung transplant spirometry is a significant predictor of increased mortality and chronic lung allograft dysfunction.","volume":"40","author":"Paraskeva","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"R24-20250219","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.healun.2018.02.014","article-title":"Baseline lung allograft dysfunction is associated with impaired survival after double-lung transplantation.","volume":"37","author":"Liu","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"R25-20250219","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.healun.2017.07.016","article-title":"The registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult lung and heart-lung transplantation report-2017; focus theme: allograft ischemic time.","volume":"36","author":"Chambers","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R26-20250219","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.healun.2020.08.008","article-title":"Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.","volume":"39","author":"Leuschner","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R27-20250219","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1124\/pharmrev.123.000834","article-title":"Lymphocyte depleting and modulating therapies for chronic lung allograft dysfunction.","volume":"75","author":"Bos","year":"2023","journal-title":"Pharmacol Rev"},{"key":"R28-20250219","doi-asserted-by":"crossref","first-page":"11551","DOI":"10.3389\/ti.2023.11551","article-title":"A European multi-center analysis of extracorporeal photopheresis as therapy for chronic lung allograft dysfunction.","volume":"36","author":"Benazzo","year":"2024","journal-title":"Transpl Int"},{"key":"R29-20250219","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000431382","article-title":"Long-term off-line extracorporeal photochemotherapy in patients with chronic lung allograft rejection not responsive to conventional treatment: a 10-year single-centre analysis.","volume":"90","author":"Del Fante","year":"2015","journal-title":"Respiration"},{"key":"R30-20250219","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.healun.2012.05.002","article-title":"A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation.","volume":"31","author":"Jaksch","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"R31-20250219","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/tme.12779","article-title":"Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction.","volume":"31","author":"Hage","year":"2021","journal-title":"Transfus Med"},{"key":"R32-20250219","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/thoraxjnl-2014-205998","article-title":"A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation.","volume":"70","author":"Corris","year":"2015","journal-title":"Thorax"},{"key":"R33-20250219","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.tp.0000295981.84633.bc","article-title":"Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.","volume":"85","author":"Gottlieb","year":"2008","journal-title":"Transplantation"},{"key":"R34-20250219","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/ctr.12401","article-title":"Azithromycin improves lung function in patients with post-lung transplant bronchiolitis obliterans syndrome: a meta-analysis.","volume":"28","author":"Kingah","year":"2014","journal-title":"Clin Transplant"},{"key":"R35-20250219","doi-asserted-by":"crossref","first-page":"e0193564","DOI":"10.1371\/journal.pone.0193564","article-title":"Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a randomized controlled trial.","volume":"13","author":"Ruttens","year":"2018","journal-title":"PLoS One"},{"key":"R36-20250219","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/sctm.16-0372","article-title":"Mesenchymal stromal cell therapy for chronic lung allograft dysfunction: results of a first-in-man study.","volume":"6","author":"Chambers","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"R37-20250219","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.healun.2024.02.016","article-title":"The Assist CLAD Study\u2014mesenchymal stromal cell therapy in chronic lung allograft dysfunction.","volume":"43","author":"Chambers","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"R38-20250219","doi-asserted-by":"crossref","first-page":"210050","DOI":"10.1183\/16000617.0050-2021","article-title":"Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review.","volume":"30","author":"Bos","year":"2021","journal-title":"Eur Respir Rev"},{"key":"R39-20250219","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1111\/ajt.15019","article-title":"Pirfenidone in restrictive allograft syndrome after lung transplantation: a case series.","volume":"18","author":"Vos","year":"2018","journal-title":"Am J Transplant"},{"key":"R40-20250219","doi-asserted-by":"crossref","first-page":"S523","DOI":"10.1016\/j.healun.2023.02.1435","article-title":"(1225) Results from randomized trial of pirfenidone in patients with chronic rejection (STOP-CLAD study).","volume":"42","author":"Combs","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"R41-20250219","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1053-2498(99)00072-8","article-title":"Cyclophosphamide rescue therapy for chronic rejection after lung transplantation.","volume":"18","author":"Verleden","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"R42-20250219","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S1053-2498(02)00815-X","article-title":"Effect of switching from cyclosporine to tacrolimus on exhaled nitric oxide and pulmonary function in patients with chronic rejection after lung transplantation.","volume":"22","author":"Verleden","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"R43-20250219","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1432-2277.2011.01248.x","article-title":"Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study.","volume":"24","author":"Verleden","year":"2011","journal-title":"Transpl Int"},{"key":"R44-20250219","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/TP.0000000000004270","article-title":"Biomarkers for chronic lung allograft dysfunction: ready for prime time?","volume":"107","author":"Verleden","year":"2023","journal-title":"Transplantation"},{"key":"R45-20250219","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.3390\/biomedicines10123277","article-title":"Markers of bronchiolitis obliterans syndrome after lung transplant: between old knowledge and future perspective.","volume":"10","author":"Cavallaro","year":"2022","journal-title":"Biomedicines"},{"key":"R46-20250219","doi-asserted-by":"crossref","first-page":"e795","DOI":"10.1016\/S2589-7500(21)00209-0","article-title":"Dynamic prediction of renal survival among deeply phenotyped kidney transplant recipients using artificial intelligence: an observational, international, multicohort study.","volume":"3","author":"Raynaud","year":"2021","journal-title":"Lancet Digit Health"},{"key":"R47-20250219","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.kint.2020.07.025","article-title":"Trajectories of glomerular filtration rate and progression to end stage kidney disease after kidney transplantation.","volume":"99","author":"Raynaud","year":"2021","journal-title":"Kidney Int"},{"key":"R48-20250219","doi-asserted-by":"crossref","first-page":"1126697","DOI":"10.3389\/fmed.2023.1126697","article-title":"Systems prediction of chronic lung allograft dysfunction: results and perspectives from the cohort of lung transplantation and systems prediction of chronic lung allograft dysfunction cohorts.","volume":"10","author":"Pison","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R49-20250219","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.healun.2022.09.022","article-title":"Assessing treatment outcomes in CLAD: the Hannover-extracorporeal photopheresis model.","volume":"42","author":"Greer","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"R50-20250219","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.healun.2022.12.001","article-title":"Laparoscopic fundoplication after lung transplantation does not appear to alter lung function trajectory.","volume":"42","author":"Frankel","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"R51-20250219","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1106\/7YOJ-RUKC-P7GV-V1UV","article-title":"Medical management considerations for patients with lung transplantation.","volume":"14","author":"Dupuis","year":"2001","journal-title":"J Pharmacy Practice"},{"key":"R52-20250219","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/00000478-199209000-00006","article-title":"Interstitial and airspace granulation tissue reactions in lung transplant recipients.","volume":"16","author":"Yousem","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"R53-20250219","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00000478-199305000-00008","article-title":"Lymphocytic bronchitis\/bronchiolitis in lung allograft recipients.","volume":"17","author":"Yousem","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"R54-20250219","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/thx.2008.104133","article-title":"Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation.","volume":"64","author":"Borthwick","year":"2009","journal-title":"Thorax"},{"key":"R55-20250219","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/ajt.12065","article-title":"TNF\u03b1 from classically activated macrophages accentuates epithelial to mesenchymal transition in obliterative bronchiolitis.","volume":"13","author":"Borthwick","year":"2013","journal-title":"Am J transplant"},{"key":"R56-20250219","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12931-017-0690-y","article-title":"TLR3 promotes MMP-9 production in primary human airway epithelial cells through Wnt\/\u03b2-catenin signaling.","volume":"18","author":"Royer","year":"2017","journal-title":"Respir Res"},{"key":"R57-20250219","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13019-017-0673-6","article-title":"The role of epithelial-mesenchymal transition in the post-lung transplantation bronchiolitis obliterans.","volume":"12","author":"Zhang","year":"2017","journal-title":"J Cardiothorac Surg"},{"key":"R58-20250219","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/ajt.14166","article-title":"T cells promote bronchial epithelial cell secretion of matrix metalloproteinase-9 via a C-C chemokine receptor type 2 pathway: implications for chronic lung allograft dysfunction.","volume":"17","author":"Pain","year":"2017","journal-title":"Am J Transplant"},{"key":"R59-20250219","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.healun.2011.12.015","article-title":"Revisiting the pathologic finding of diffuse alveolar damage after lung transplantation.","volume":"31","author":"Sato","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"R60-20250219","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/modpathol.2012.171","article-title":"Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosis.","volume":"26","author":"Ofek","year":"2013","journal-title":"Mod Pathol"},{"key":"R61-20250219","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/his.13171","article-title":"Restrictive allograft syndrome and idiopathic pleuroparenchymal fibroelastosis: do they really have the same histology?","volume":"70","author":"Montero","year":"2017","journal-title":"Histopathology"},{"key":"R62-20250219","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.healun.2011.07.010","article-title":"Comparison of serum KL-6 versus bronchoalveolar lavage neutrophilia for the diagnosis of bronchiolitis obliterans in lung transplantation.","volume":"30","author":"Ohshimo","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R63-20250219","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","article-title":"A common MUC5B promoter polymorphism and pulmonary fibrosis.","volume":"364","author":"Seibold","year":"2011","journal-title":"N Engl J Med"},{"key":"R64-20250219","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/ajt.13589","article-title":"Antibody-mediated rejection in lung transplantation: clinical outcomes and donor-specific antibody characteristics.","volume":"16","author":"Roux","year":"2016","journal-title":"Am J Transplant"},{"key":"R65-20250219","doi-asserted-by":"crossref","first-page":"1701248","DOI":"10.1183\/13993003.01248-2017","article-title":"Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation.","volume":"50","author":"Verleden","year":"2017","journal-title":"Eur Respir J"},{"key":"R66-20250219","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/0003-4975(90)90015-X","article-title":"Donor-specific cytotoxicity testing: an advance in detecting pulmonary allograft rejection.","volume":"49","author":"Dal Col","year":"1990","journal-title":"Ann Thorac Surg"},{"key":"R67-20250219","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00007890-198611000-00005","article-title":"Concanavalin A-dependent cell-mediated cytotoxicity in bronchoalveolar lavage fluid. Correlation with lung allograft rejection in mongrel dogs during cyclosporine dose tapering.","volume":"42","author":"Norin","year":"1986","journal-title":"Transplantation"},{"key":"R68-20250219","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0003-4975(94)91068-5","article-title":"Experimental large-animal model of obliterative bronchiolitis after lung transplantation.","volume":"58","author":"al-Dossari","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"R69-20250219","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00007890-200202150-00020","article-title":"Modeling chronic lung allograft rejection in miniature swine.","volume":"73","author":"Allan","year":"2002","journal-title":"Transplantation"},{"key":"R70-20250219","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/0022-3468(92)90578-U","article-title":"Reduced-size lung transplantation from adult to neonatal sheep.","volume":"27","author":"Lillehei","year":"1992","journal-title":"J Pediatr Surg"},{"key":"R71-20250219","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1111\/ajt.13274","article-title":"Tolerance of lung allografts achieved in nonhuman primates via mixed hematopoietic chimerism.","volume":"15","author":"Tonsho","year":"2015","journal-title":"Am J Transplant"},{"key":"R72-20250219","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/ajt.13130","article-title":"Long-term lung transplantation in nonhuman primates.","volume":"15","author":"Aoyama","year":"2015","journal-title":"Am J Transplant"},{"key":"R73-20250219","first-page":"1945","article-title":"Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways.","volume":"142","author":"Hertz","year":"1993","journal-title":"Am J Pathol"},{"key":"R74-20250219","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/micr.20329","article-title":"Experimental orthotopic tracheal transplantation: the Stanford technique.","volume":"27","author":"Schrepfer","year":"2007","journal-title":"Microsurgery"},{"key":"R75-20250219","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-6143.2004.00680.x","article-title":"A novel model for post-transplant obliterative airway disease reveals angiogenesis from the pulmonary circulation.","volume":"5","author":"Dutly","year":"2005","journal-title":"Am J Transplant"},{"key":"R76-20250219","doi-asserted-by":"crossref","first-page":"e93121","DOI":"10.1172\/jci.insight.93121","article-title":"Models of lung transplant research: a consensus statement from the National Heart, Lung, and Blood Institute workshop.","volume":"2","author":"Lama","year":"2017","journal-title":"JCI Insight"},{"key":"R77-20250219","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.athoracsur.2012.01.096","article-title":"Simplified rat lung transplantation using a new cuff technique.","volume":"93","author":"Goto","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"R78-20250219","first-page":"7","article-title":"Surgical technique of experimental lung transplantation in rabbits.","volume":"11","author":"Yoshida","year":"2005","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"R79-20250219","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1600-6143.2012.04337.x","article-title":"Ferret lung transplant: an orthotopic model of obliterative bronchiolitis.","volume":"13","author":"Sui","year":"2013","journal-title":"Am J Transplant"},{"key":"R80-20250219","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1164\/rccm.201707-1368OC","article-title":"Depletion of airway submucosal glands and TP63+KRT5+ basal cells in obliterative bronchiolitis.","volume":"197","author":"Swatek","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R81-20250219","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1097\/TP.0000000000004148","article-title":"Ferret lung transplantation models differential lymphoid aggregate morphology between restrictive and obstructive forms of chronic lung allograft dysfunction.","volume":"106","author":"Lynch","year":"2022","journal-title":"Transplantation"},{"key":"R82-20250219","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1600-6143.2007.01819.x","article-title":"A mouse model of orthotopic vascularized aerated lung transplantation.","volume":"7","author":"Okazaki","year":"2007","journal-title":"Am J Transplant"},{"key":"R83-20250219","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.ajpath.2015.03.002","article-title":"Local origin of mesenchymal cells in a murine orthotopic lung transplantation model of bronchiolitis obliterans.","volume":"185","author":"Mimura","year":"2015","journal-title":"Am J Pathol"},{"key":"R84-20250219","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1600-6143.2011.03482.x","article-title":"Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation.","volume":"11","author":"Fan","year":"2011","journal-title":"Am J Transplant"},{"key":"R85-20250219","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/ajt.13215","article-title":"CD4 T cells but not Th17 cells are required for mouse lung transplant obliterative bronchiolitis.","volume":"15","author":"Wu","year":"2015","journal-title":"Am J Transplant"},{"key":"R86-20250219","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1111\/ajt.15550","article-title":"A B cell-dependent pathway drives chronic lung allograft rejection after ischemia-reperfusion injury in mice.","volume":"19","author":"Watanabe","year":"2019","journal-title":"Am J Transplant"},{"key":"R87-20250219","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.healun.2022.05.009","article-title":"Loss of stromal cell Thy-1 plays a critical role in lipopolysaccharide induced chronic lung allograft dysfunction.","volume":"41","author":"Hata","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"R88-20250219","doi-asserted-by":"crossref","first-page":"e124732","DOI":"10.1172\/jci.insight.124732","article-title":"An obligatory role for club cells in preventing obliterative bronchiolitis in lung transplants.","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"key":"R89-20250219","doi-asserted-by":"crossref","first-page":"e159229","DOI":"10.1172\/JCI159229","article-title":"Reprogramming alveolar macrophage responses to TGF-\u03b2 reveals CCR2+ monocyte activity that promotes bronchiolitis obliterans syndrome.","volume":"132","author":"Liu","year":"2022","journal-title":"J Clin Invest"},{"key":"R90-20250219","doi-asserted-by":"crossref","first-page":"e136533","DOI":"10.1172\/jci.insight.136533","article-title":"Humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunction.","volume":"5","author":"Misumi","year":"2020","journal-title":"JCI Insight"},{"key":"R91-20250219","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11908-016-0529-6","article-title":"Infectious triggers of chronic lung allograft dysfunction.","volume":"18","author":"Gregson","year":"2016","journal-title":"Curr Infect Dis Rep"},{"key":"R92-20250219","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1164\/rccm.200310-1359OC","article-title":"Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death.","volume":"170","author":"Khalifah","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R93-20250219","doi-asserted-by":"crossref","first-page":"e370","DOI":"10.1097\/TXD.0000000000000808","article-title":"Viral respiratory tract infection during the first postoperative year is a risk factor for chronic rejection after lung transplantation.","volume":"4","author":"Magnusson","year":"2018","journal-title":"Transplant Direct"},{"key":"R94-20250219","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1097\/TP.0000000000001346","article-title":"Graft loss and CLAD-onset is hastened by viral pneumonia after lung transplantation.","volume":"100","author":"Allyn","year":"2016","journal-title":"Transplantation"},{"key":"R95-20250219","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12865-014-0041-4","article-title":"Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection.","volume":"15","author":"Foronjy","year":"2014","journal-title":"BMC Immunol"},{"key":"R96-20250219","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.celrep.2015.05.012","article-title":"Acute lung injury results from innate sensing of viruses by an ER stress pathway.","volume":"11","author":"Hrincius","year":"2015","journal-title":"Cell Rep"},{"key":"R97-20250219","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2567.2003.01738.x","article-title":"The MHC class I antigen presentation pathway: strategies for viral immune evasion.","volume":"110","author":"Hewitt","year":"2003","journal-title":"Immunology"},{"key":"R98-20250219","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.healun.2019.12.009","article-title":"Respiratory viral infection in lung transplantation induces exosomes that trigger chronic rejection.","volume":"39","author":"Gunasekaran","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R99-20250219","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1399-3062.2009.00422.x","article-title":"Clinical spectrum of gram-positive infections in lung transplantation.","volume":"11","author":"Gupta","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"R100-20250219","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1164\/rccm.201207-1228OC","article-title":"Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation.","volume":"187","author":"Gregson","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R101-20250219","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.healun.2011.01.701","article-title":"A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients.","volume":"30","author":"Husain","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R102-20250219","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.rmed.2008.11.015","article-title":"Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis.","volume":"103","author":"Gottlieb","year":"2009","journal-title":"Respir Med"},{"key":"R103-20250219","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12866-018-1231-7","article-title":"Impact of gram negative bacteria airway recolonization on the occurrence of chronic lung allograft dysfunction after lung transplantation in a population of cystic fibrosis patients.","volume":"18","author":"Orfanos","year":"2018","journal-title":"BMC Microbiol"},{"key":"R104-20250219","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/ajt.13029","article-title":"Staphylococcus via an interaction with the ELR+ CXC chemokine ENA-78 is associated with BOS.","volume":"15","author":"Gregson","year":"2015","journal-title":"Am J Transplant"},{"key":"R105-20250219","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.healun.2022.09.018","article-title":"IL-33 mediates Pseudomonas induced airway fibrogenesis and is associated with CLAD.","volume":"42","author":"Banday","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"R106-20250219","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.healun.2021.05.016","article-title":"Inferior outcomes in lung transplant recipients with serum Pseudomonas aeruginosa specific cloaking antibodies.","volume":"40","author":"Divithotawela","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"R107-20250219","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/ajt.15687","article-title":"Pseudomonas aeruginosa and acute rejection independently increase the risk of donor-specific antibodies after lung transplantation.","volume":"20","author":"Kulkarni","year":"2020","journal-title":"Am J Transplant"},{"key":"R108-20250219","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1183\/09031936.00088410","article-title":"Pseudomonas aeruginosa accentuates epithelial-to-mesenchymal transition in the airway.","volume":"37","author":"Borthwick","year":"2011","journal-title":"Eur Respir J"},{"key":"R109-20250219","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1139\/w99-044","article-title":"Recombinant Pseudomonas exoenzyme S and exoenzyme S from Pseudomonas aeruginosa DG1 share the ability to stimulate T lymphocyte proliferation.","volume":"45","author":"Bruno","year":"1999","journal-title":"Can J Microbiol"},{"key":"R110-20250219","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.4049\/jimmunol.1201683","article-title":"Cutting edge: Pseudomonas aeruginosa abolishes established lung transplant tolerance by stimulating B7 expression on neutrophils.","volume":"189","author":"Yamamoto","year":"2012","journal-title":"J Immunol"},{"key":"R111-20250219","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/ajt.12131","article-title":"Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study.","volume":"13","author":"Weigt","year":"2013","journal-title":"Am J Transplant"},{"key":"R112-20250219","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.healun.2023.02.005","article-title":"Invasive fungal infections after respiratory viral infections in lung transplant recipients are associated with lung allograft failure and chronic lung allograft dysfunction within 1 year.","volume":"42","author":"Permpalung","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"R113-20250219","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.1016\/j.healun.2020.01.679","article-title":"Fungal prophylaxis and chronic lung allograft dysfunction.","volume":"39","author":"Beach","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R114-20250219","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.21037\/jtd-2021-26","article-title":"Fungal infections in lung transplantation.","volume":"13","author":"Samanta","year":"2021","journal-title":"J Thorac Dis"},{"key":"R115-20250219","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/j.1600-6143.2006.01357.x","article-title":"The effect of reflux and bile acid aspiration on the lung allograft and its surfactant and innate immunity molecules SP-A and SP-D.","volume":"6","author":"D\u2019Ovidio","year":"2006","journal-title":"Am J Transplant"},{"key":"R116-20250219","doi-asserted-by":"crossref","first-page":"00222-2023","DOI":"10.1183\/23120541.00222-2023","article-title":"Oesophageal stasis is a risk factor for chronic lung allograft dysfunction and allograft failure in lung transplant recipients.","volume":"9","author":"Ramendra","year":"2023","journal-title":"ERJ Open Res"},{"key":"R117-20250219","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/ajt.12631","article-title":"Bile acid aspiration associated with lung chemical profile linked to other biomarkers of injury after lung transplantation.","volume":"14","author":"Neujahr","year":"2014","journal-title":"Am J Transplant"},{"key":"R118-20250219","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.healun.2023.02.055","article-title":"Airway pepsinogen A4 is a specific marker of gastric aspiration and predicts chronic lung allograft dysfunction in lung transplant recipients.","volume":"42","author":"Ramendra","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"R119-20250219","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.healun.2020.05.006","article-title":"Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspiration.","volume":"39","author":"Zhang","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R120-20250219","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1183\/09031936.00064807","article-title":"Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection.","volume":"31","author":"Blondeau","year":"2008","journal-title":"Eur Respir J"},{"key":"R121-20250219","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.healun.2009.05.040","article-title":"Gastroesophageal reflux in bronchiolitis obliterans syndrome: a new perspective.","volume":"28","author":"King","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R122-20250219","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1097\/MCG.0b013e3181d47dc4","article-title":"Gastric juice from patients \u201con\u201d acid suppressive therapy can still provoke a significant inflammatory reaction by human bronchial epithelial cells.","volume":"44","author":"Mertens","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"R123-20250219","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.healun.2008.05.022","article-title":"Airway colonization and gastric aspiration after lung transplantation: do birds of a feather flock together?","volume":"27","author":"Vos","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R124-20250219","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1164\/rccm.202110-2413OC","article-title":"Lung allograft microbiome association with gastroesophageal reflux, inflammation, and allograft dysfunction.","volume":"206","author":"Schneeberger","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"R125-20250219","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1164\/rccm.200303-447OC","article-title":"The role of innate immunity in acute allograft rejection after lung transplantation.","volume":"168","author":"Palmer","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R126-20250219","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.healun.2009.12.013","article-title":"Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation.","volume":"29","author":"Kastelijn","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R127-20250219","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1111\/ajt.12368","article-title":"Receptor for advanced glycation end products (RAGE) on iNKT cells mediates lung ischemia\u2013reperfusion injury.","volume":"13","author":"Sharma","year":"2013","journal-title":"Am J Transplant"},{"key":"R128-20250219","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1164\/rccm.201308-1481OC","article-title":"Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.","volume":"189","author":"Todd","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R129-20250219","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jtcvs.2009.04.049","article-title":"Apyrase treatment prevents ischemia\u2013reperfusion injury in rat lung isografts.","volume":"138","author":"Sugimoto","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R130-20250219","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/ajt.15232","article-title":"Mitochondrial damage-associated molecular patterns released by lung transplants are associated with primary graft dysfunction.","volume":"19","author":"Scozzi","year":"2019","journal-title":"Am J Transplant"},{"key":"R131-20250219","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jtcvs.2010.09.009","article-title":"Short- and long-term outcomes of 1000 adult lung transplant recipients at a single center.","volume":"141","author":"Kreisel","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R132-20250219","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.athoracsur.2008.03.073","article-title":"Immunological link between primary graft dysfunction and chronic lung allograft rejection.","volume":"86","author":"Bharat","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"R133-20250219","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1165\/rcmb.2018-0207OC","article-title":"Prolonged cold ischemia induces necroptotic cell death in ischemia-reperfusion injury and contributes to primary graft dysfunction after lung transplantation.","volume":"61","author":"Wang","year":"2019","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R134-20250219","doi-asserted-by":"crossref","first-page":"e2111537119","DOI":"10.1073\/pnas.2111537119","article-title":"Necroptosis triggers spatially restricted neutrophil-mediated vascular damage during lung ischemia reperfusion injury.","volume":"119","author":"Li","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R135-20250219","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1183\/09031936.98.12010082","article-title":"Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung.","volume":"12","author":"Riise","year":"1998","journal-title":"Eur Respir J"},{"key":"R136-20250219","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.healun.2009.01.014","article-title":"Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.","volume":"28","author":"Neurohr","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R137-20250219","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1164\/ajrccm.164.1.2006096","article-title":"Neutrophils, unopposed neutrophil elastase, and alpha1-antiprotease defenses following human lung transplantation.","volume":"164","author":"Meyer","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R138-20250219","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1111\/j.1600-6143.2007.01850.x","article-title":"Lung transplant metalloproteinase levels are elevated prior to bronchiolitis obliterans syndrome.","volume":"7","author":"Smith","year":"2007","journal-title":"Am J Transplant"},{"key":"R139-20250219","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12931-024-02707-3","article-title":"Blood MMP-9 measured at 2 years after lung transplantation as a prognostic biomarker of chronic lung allograft dysfunction.","volume":"25","author":"Tissot","year":"2024","journal-title":"Respir Res"},{"key":"R140-20250219","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1097\/00007890-200005150-00020","article-title":"Evidence for oxidative stress in bronchiolitis obliterans syndrome after lung and heart-lung transplantation. The Munich Lung Transplant Group.","volume":"69","author":"Behr","year":"2000","journal-title":"Transplantation"},{"key":"R141-20250219","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/TP.0b013e3182a6bae2","article-title":"Elevated bronchoalveolar lavage eosinophilia correlates with poor outcome after lung transplantation.","volume":"97","author":"Verleden","year":"2014","journal-title":"Transplantation"},{"key":"R142-20250219","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3390\/cells9112516","article-title":"Peripheral blood eosinophilia is associated with poor outcome post-lung transplantation.","volume":"9","author":"Kaes","year":"2020","journal-title":"Cells"},{"key":"R143-20250219","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/tri.13760","article-title":"Eosinophils in transbronchial biopsies: a predictor of chronic lung allograft dysfunction and reduced survival after lung transplantation\u2014a retrospective single\u2010center cohort study.","volume":"34","author":"Darley","year":"2021","journal-title":"Transpl Int"},{"key":"R144-20250219","doi-asserted-by":"crossref","first-page":"9660","DOI":"10.1073\/pnas.96.17.9660","article-title":"Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta).","volume":"96","author":"Levi-Schaffer","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R145-20250219","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10753-007-9032-4","article-title":"Eosinophil cationic protein stimulates TGF-beta1 release by human lung fibroblasts in vitro.","volume":"30","author":"Zagai","year":"2007","journal-title":"Inflammation"},{"key":"R146-20250219","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-3083.2009.02233.x","article-title":"Eosinophil cationic protein stimulates migration of human lung fibroblasts in vitro.","volume":"69","author":"Zagai","year":"2009","journal-title":"Scand J Immunol"},{"key":"R147-20250219","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.4049\/jimmunol.123.6.2925","article-title":"Cytotoxic properties of the eosinophil major basic protein.","volume":"123","author":"Gleich","year":"1979","journal-title":"J Immunol"},{"key":"R148-20250219","doi-asserted-by":"crossref","first-page":"e96455","DOI":"10.1172\/jci.insight.96455","article-title":"Eosinophils promote inducible NOS-mediated lung allograft acceptance.","volume":"2","author":"Onyema","year":"2017","journal-title":"JCI Insight"},{"key":"R149-20250219","doi-asserted-by":"crossref","first-page":"e128241","DOI":"10.1172\/jci.insight.128241","article-title":"Eosinophils downregulate lung alloimmunity by decreasing TCR signal transduction.","volume":"4","author":"Onyema","year":"2019","journal-title":"JCI Insight"},{"key":"R150-20250219","doi-asserted-by":"crossref","first-page":"e168911","DOI":"10.1172\/jci.insight.168911","article-title":"Eosinophils restrain humoral alloimmunity after lung transplantation.","volume":"9","author":"Mei","year":"2024","journal-title":"JCI Insight"},{"key":"R151-20250219","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1172\/JCI200112214","article-title":"Critical role for the chemokine MCP-1\/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome.","volume":"108","author":"Belperio","year":"2001","journal-title":"J Clin Invest"},{"key":"R152-20250219","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1172\/JCI98436","article-title":"Spleen-derived classical monocytes mediate lung ischemia-reperfusion injury through IL-1\u03b2.","volume":"128","author":"Hsiao","year":"2018","journal-title":"J Clin Invest"},{"key":"R153-20250219","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/thoraxjnl-2016-208977","article-title":"Intravascular donor monocytes play a central role in lung transplant ischaemia-reperfusion injury.","volume":"73","author":"Tatham","year":"2018","journal-title":"Thorax"},{"key":"R154-20250219","doi-asserted-by":"crossref","first-page":"eaal4508","DOI":"10.1126\/scitranslmed.aal4508","article-title":"Donor pulmonary intravascular nonclassical monocytes recruit recipient neutrophils and mediate primary lung allograft dysfunction.","volume":"9","author":"Zheng","year":"2017","journal-title":"Sci Transl Med"},{"key":"R155-20250219","doi-asserted-by":"crossref","first-page":"e147282","DOI":"10.1172\/jci.insight.147282","article-title":"Crosstalk between nonclassical monocytes and alveolar macrophages mediates transplant ischemia-reperfusion injury through classical monocyte recruitment.","volume":"6","author":"Kurihara","year":"2021","journal-title":"JCI Insight"},{"key":"R156-20250219","doi-asserted-by":"crossref","first-page":"e157262","DOI":"10.1172\/JCI157262","article-title":"CD11b suppresses TLR activation of nonclassical monocytes to reduce primary graft dysfunction after lung transplantation.","volume":"132","author":"Querrey","year":"2022","journal-title":"J Clin Invest"},{"key":"R157-20250219","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.4049\/jimmunol.180.5.3019","article-title":"Blood monocyte subsets differentially give rise to CD103+ and CD103- pulmonary dendritic cell populations.","volume":"180","author":"Jakubzick","year":"2008","journal-title":"J Immunol"},{"key":"R158-20250219","doi-asserted-by":"crossref","first-page":"e20191236","DOI":"10.1084\/jem.20191236","article-title":"Dynamics of human monocytes and airway macrophages during healthy aging and after transplant.","volume":"217","author":"Byrne","year":"2020","journal-title":"J Exp Med"},{"key":"R159-20250219","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/thx.2008.104067","article-title":"Bronchial epithelial cells cultured from clinically stable lung allograft patients promote the development of macrophages from monocytes rather than dendritic cells.","volume":"64","author":"Ward","year":"2009","journal-title":"Thorax"},{"key":"R160-20250219","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1126\/science.aax4040","article-title":"PIRs mediate innate myeloid cell memory to nonself MHC molecules.","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"R161-20250219","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trim.2008.01.004","article-title":"Natural killer cells and lung transplantation, roles in rejection, infection, and tolerance.","volume":"19","author":"Fildes","year":"2008","journal-title":"Transpl Immunol"},{"key":"R162-20250219","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.healun.2012.04.007","article-title":"Bronchiolitis obliterans syndrome is associated with increased peripheral blood natural killer and natural killer T-like granzymes, perforin, and T-helper-type 1 pro-inflammatory cytokines.","volume":"31","author":"Hodge","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"R163-20250219","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/TP.0000000000002450","article-title":"NKG2C natural killer cells in bronchoalveolar lavage are associated with cytomegalovirus viremia and poor outcomes in lung allograft recipients.","volume":"103","author":"Calabrese","year":"2019","journal-title":"Transplantation"},{"key":"R164-20250219","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ajt.2022.10.006","article-title":"CD16+ natural killer cells in bronchoalveolar lavage are associated with antibody-mediated rejection and chronic lung allograft dysfunction.","volume":"23","author":"Calabrese","year":"2023","journal-title":"Am J Transplant"},{"key":"R165-20250219","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1164\/rccm.201209-1749OC","article-title":"Cytokine complex-expanded natural killer cells improve allogeneic lung transplant function via depletion of donor dendritic cells.","volume":"187","author":"Jungraithmayr","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R166-20250219","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1016\/j.healun.2021.01.467","article-title":"Pulmonary macrophage subsets associated with lung allograft dysfunction revealed by single-cell RNA sequencing.","volume":"40","author":"Moshkelgosha","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"R167-20250219","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.healun.2022.01.042","article-title":"Single-cell RNA sequencing identifies unique pulmonary macrophage subsets associated with chronic lung allograft dysfunction.","volume":"41","author":"Duong","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"R168-20250219","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.healun.2024.02.007","article-title":"Macrophage and CD8 T cell discordance are associated with acute lung allograft dysfunction progression.","volume":"43","author":"Calabrese","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"R169-20250219","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.intimp.2015.02.003","article-title":"IL-25 regulates the polarization of macrophages and attenuates obliterative bronchiolitis in murine trachea transplantation models.","volume":"25","author":"Liu","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"R170-20250219","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/00007890-199803150-00008","article-title":"HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome.","volume":"65","author":"Sundaresan","year":"1998","journal-title":"Transplantation"},{"key":"R171-20250219","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.humimm.2010.02.021","article-title":"Development of antibodies to human leukocyte antigen precedes development of antibodies to major histocompatibility class I-related chain A and are significantly associated with development of chronic rejection after human lung transplantation.","volume":"71","author":"Angaswamy","year":"2010","journal-title":"Hum Immunol"},{"key":"R172-20250219","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.healun.2012.10.007","article-title":"Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.","volume":"32","author":"Lobo","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R173-20250219","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/TP.0b013e31827afb0f","article-title":"Lung transplantation in patients with pretransplantation donor-specific antibodies detected by Luminex assay.","volume":"95","author":"Brugi\u00e8re","year":"2013","journal-title":"Transplantation"},{"key":"R174-20250219","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0198-8859(03)00038-7","article-title":"Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome.","volume":"64","author":"Jaramillo","year":"2003","journal-title":"Hum Immunol"},{"key":"R175-20250219","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.ajt.2024.02.020","article-title":"Fibrotic progression from acute cellular rejection is dependent on secondary lymphoid organs in a mouse model of chronic lung allograft dysfunction.","volume":"24","author":"Mineura","year":"2024","journal-title":"Am J Transplant"},{"key":"R176-20250219","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1600-6143.2012.04079.x","article-title":"Antibodies to K-\u03b1 1 tubulin and collagen V are associated with chronic rejection after lung transplantation.","volume":"12","author":"Hachem","year":"2012","journal-title":"Am J Transplant"},{"key":"R177-20250219","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.healun.2023.12.007","article-title":"Chronic lung allograft dysfunction is associated with an increased number of non-HLA antibodies.","volume":"43","author":"Xu","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"R178-20250219","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/ajt.13915","article-title":"Donor-derived exosomes with lung self-antigens in human lung allograft rejection.","volume":"17","author":"Gunasekaran","year":"2017","journal-title":"Am J Transplant"},{"key":"R179-20250219","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1172\/JCI28031","article-title":"IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants.","volume":"117","author":"Burlingham","year":"2007","journal-title":"J Clin Invest"},{"key":"R180-20250219","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1111\/ajt.12405","article-title":"Immune cell-derived C3a and C5a costimulate human T cell alloimmunity.","volume":"13","author":"Cravedi","year":"2013","journal-title":"Am J Transplant"},{"key":"R181-20250219","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MOT.0000000000000040","article-title":"Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms.","volume":"19","author":"Valenzuela","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"key":"R182-20250219","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.4049\/jimmunol.1201434","article-title":"HLA class I antibodies trigger increased adherence of monocytes to endothelial cells by eliciting an increase in endothelial P-selectin and, depending on subclass, by engaging Fc\u03b3Rs.","volume":"190","author":"Valenzuela","year":"2013","journal-title":"J Immunol"},{"key":"R183-20250219","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/01.tp.0000181161.60638.fa","article-title":"The significance of a single episode of minimal acute rejection after lung transplantation.","volume":"80","author":"Hachem","year":"2005","journal-title":"Transplantation"},{"key":"R184-20250219","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1164\/rccm.200302-165OC","article-title":"Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis.","volume":"170","author":"Hopkins","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R185-20250219","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1111\/j.1600-6143.2006.01494.x","article-title":"Direct versus indirect allorecognition: visualization of dendritic cell distribution and interactions during rejection and tolerization.","volume":"6","author":"Ochando","year":"2006","journal-title":"Am J Transplant"},{"key":"R186-20250219","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nm0302-233","article-title":"Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition.","volume":"8","author":"Kreisel","year":"2002","journal-title":"Nat Med"},{"key":"R187-20250219","doi-asserted-by":"crossref","first-page":"aaf8759","DOI":"10.1126\/sciimmunol.aaf8759","article-title":"Donor exosomes rather than passenger leukocytes initiate alloreactive T cell responses after transplantation.","volume":"1","author":"Marino","year":"2016","journal-title":"Sci Immunol"},{"key":"R188-20250219","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1172\/JCI84577","article-title":"Donor dendritic cell-derived exosomes promote allograft-targeting immune response.","volume":"126","author":"Liu","year":"2016","journal-title":"J Clin Invest"},{"key":"R189-20250219","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1111\/ajt.17023","article-title":"Donor extracellular vesicle trafficking via the pleural space represents a novel pathway for allorecognition after lung transplantation.","volume":"22","author":"Habertheuer","year":"2022","journal-title":"Am J Transplant"},{"key":"R190-20250219","doi-asserted-by":"crossref","first-page":"eabg1046","DOI":"10.1126\/scitranslmed.abg1046","article-title":"Inverted direct allorecognition triggers early donor-specific antibody responses after transplantation.","volume":"14","author":"Charmetant","year":"2022","journal-title":"Sci Transl Med"},{"key":"R191-20250219","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1073\/pnas.90.8.3373","article-title":"The role of \u201cindirect\u201d recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice.","volume":"90","author":"Auchincloss","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R192-20250219","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1084\/jem.166.5.1229","article-title":"Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, Functionally monospecific bioassays, and monoclonal antibodies.","volume":"166","author":"Cherwinski","year":"1987","journal-title":"J Exp Med"},{"key":"R193-20250219","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17\u2013producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"R194-20250219","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.1241680","article-title":"T follicular helper cell dynamics in germinal centers.","volume":"341","author":"Shulman","year":"2013","journal-title":"Science"},{"key":"R195-20250219","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4049\/jimmunol.182.3.1469","article-title":"Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis.","volume":"182","author":"Strauss","year":"2009","journal-title":"J Immunol"},{"key":"R196-20250219","doi-asserted-by":"crossref","first-page":"e11354","DOI":"10.1371\/journal.pone.0011354","article-title":"Protection against bronchiolitis obliterans syndrome is associated with allograft CCR7+ CD45RA- T regulatory cells.","volume":"5","author":"Gregson","year":"2010","journal-title":"PLoS One"},{"key":"R197-20250219","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/ajt.14148","article-title":"Association of higher CD4+ CD25high CD127low, FoxP3+, and IL-2+ T cell frequencies early after lung transplantation with less chronic lung allograft dysfunction at two years.","volume":"17","author":"Salman","year":"2017","journal-title":"Am J Transplant"},{"key":"R198-20250219","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/01.TP.0000157278.02848.C7","article-title":"The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo.","volume":"79","author":"Lamioni","year":"2005","journal-title":"Transplantation"},{"key":"R199-20250219","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.transproceed.2006.10.227","article-title":"Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients.","volume":"39","author":"Meloni","year":"2007","journal-title":"Transplant Proc"},{"key":"R200-20250219","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00007890-198507000-00006","article-title":"Lung allograft rejection in the rat. I. Accelerated rejection caused by graft lymphocytes.","volume":"40","author":"Prop","year":"1985","journal-title":"Transplantation"},{"key":"R201-20250219","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.4049\/jimmunol.0803606","article-title":"The role of intrapulmonary de novo lymphoid tissue in obliterative bronchiolitis after lung transplantation.","volume":"182","author":"Sato","year":"2009","journal-title":"J Immunol"},{"key":"R202-20250219","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/mi.2012.30","article-title":"Lung transplant acceptance is facilitated by early events in the graft and is associated with lymphoid neogenesis.","volume":"5","author":"Li","year":"2012","journal-title":"Mucosal Immunol"},{"key":"R203-20250219","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1172\/JCI122083","article-title":"Bronchus-associated lymphoid tissue-resident Foxp3+ T lymphocytes prevent antibody-mediated lung rejection.","volume":"129","author":"Li","year":"2019","journal-title":"J Clin Invest"},{"key":"R204-20250219","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/ajt.15701","article-title":"IL-22 is required for the induction of bronchus-associated lymphoid tissue in tolerant lung allografts.","volume":"20","author":"Tanaka","year":"2020","journal-title":"Am J Transplant"},{"key":"R205-20250219","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1172\/JCI136057","article-title":"Lymphatic drainage from bronchus-associated lymphoid tissue in tolerant lung allografts promotes peripheral tolerance.","volume":"130","author":"Li","year":"2020","journal-title":"J Clin Invest"},{"key":"R206-20250219","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/MOT.0000000000000371","article-title":"Mechanisms of graft rejection after lung transplantation.","volume":"22","author":"Hsiao","year":"2017","journal-title":"Curr Opin Organ Transplant"},{"issue":"Suppl_3","key":"R207-20250219","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1513\/AnnalsATS.201607-576MG","article-title":"Mechanisms of graft rejection and immune regulation after lung transplant.","volume":"14","author":"Gauthier","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"R208-20250219","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/ajt.17028","article-title":"A pilot randomized controlled trial of de novo belatacept-based immunosuppression following anti-thymocyte globulin induction in lung transplantation.","volume":"22","author":"Huang","year":"2022","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T05:02:08Z","timestamp":1739941328000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":208,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005162","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]}}}